VNS shows durable benefits in Treatment-Resistant depression
Two-year data show that adding VNS to standard care can produce lasting symptom, function, and quality-of-life benefits in…
Study provides new insights into understanding the origins of schizophrenia
A study published in Molecular Psychiatry and led by the EHU’s Neuropsychopharmacology group, which is also a member…